Ablation With Transcatheter Edge-to-edge Repair for Atrial Functional Mitral Regurgitation and Atrial Fibrillation

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 384 participants.

Also called NCT07744035

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 384 participants (planned count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as a collaborator
Registry
  • NCT NCT07744035
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07744035. Randomized; no masking; primary purpose treatment. Start 2026-09-01 (anticipated); primary completion 2028-09-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Ablation With Transcatheter Edge-to-edge Repair for Atrial Functional Mitral Regurgitation and Atrial Fibrillation
Acronym
ATTRACTION
Condition
Atrial Functional Mitral Regurgitation
Condition
Atrial Fibrillation (AF)
Intervention (Device)
Transcatheter edge to edge repair
Intervention (Procedure)
Catheter ablation
Lead sponsor
Mao Chen (class: other)
Collaborator
Abbott (class: industry)

Record details

Record id
cardio:ct-nct07744035
Content hash
f624adb7bcba7711cdc4404094a09259bf05e32be04e14e611269f566eacb408